These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 26755885)
1. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. Sakai H; Shirakami Y; Shimizu M World J Gastroenterol; 2016 Jan; 22(1):394-406. PubMed ID: 26755885 [TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids. Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224 [TBL] [Abstract][Full Text] [Related]
3. Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis. Shimizu M; Kubota M; Tanaka T; Moriwaki H Int J Mol Sci; 2012; 13(1):579-595. PubMed ID: 22312273 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive potential of green tea catechins in hepatocellular carcinoma. Shimizu M; Shirakami Y; Sakai H; Kubota M; Kochi T; Ideta T; Miyazaki T; Moriwaki H Int J Mol Sci; 2015 Mar; 16(3):6124-39. PubMed ID: 25789501 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities. Shirakami Y; Shimizu M; Kubota M; Araki H; Tanaka T; Moriwaki H; Seishima M World J Gastroenterol; 2014 Jul; 20(27):8939-46. PubMed ID: 25083066 [TBL] [Abstract][Full Text] [Related]
6. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects. Shimizu M; Imai K; Takai K; Moriwaki H Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214 [TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of hepatocellular carcinoma by acyclic retinoid. Shimizu M; Sakai H; Moriwaki H Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201 [TBL] [Abstract][Full Text] [Related]
8. Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice. Miyazaki T; Shirakami Y; Kubota M; Ideta T; Kochi T; Sakai H; Tanaka T; Moriwaki H; Shimizu M Oncotarget; 2016 Mar; 7(9):10448-58. PubMed ID: 26871288 [TBL] [Abstract][Full Text] [Related]
9. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Shimizu M; Tanaka T; Moriwaki H Semin Immunopathol; 2013 Mar; 35(2):191-202. PubMed ID: 22945457 [TBL] [Abstract][Full Text] [Related]
10. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Shimizu M; Takai K; Moriwaki H Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086 [TBL] [Abstract][Full Text] [Related]
11. Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation. Shirakami Y; Ohnishi M; Sakai H; Tanaka T; Shimizu M Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445390 [TBL] [Abstract][Full Text] [Related]
12. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice. Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580 [TBL] [Abstract][Full Text] [Related]
13. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice. Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039 [TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. Tian Y; Wong VW; Wong GL; Yang W; Sun H; Shen J; Tong JH; Go MY; Cheung YS; Lai PB; Zhou M; Xu G; Huang TH; Yu J; To KF; Cheng AS; Chan HL Cancer Res; 2015 Nov; 75(22):4803-16. PubMed ID: 26383163 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma. Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627 [TBL] [Abstract][Full Text] [Related]
16. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016]. Pár A; Pár G Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838 [TBL] [Abstract][Full Text] [Related]
17. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Jühling F; Hamdane N; Crouchet E; Li S; El Saghire H; Mukherji A; Fujiwara N; Oudot MA; Thumann C; Saviano A; Roca Suarez AA; Goto K; Masia R; Sojoodi M; Arora G; Aikata H; Ono A; Tabrizian P; Schwartz M; Polyak SJ; Davidson I; Schmidl C; Bock C; Schuster C; Chayama K; Pessaux P; Tanabe KK; Hoshida Y; Zeisel MB; Duong FH; Fuchs BC; Baumert TF Gut; 2021 Jan; 70(1):157-169. PubMed ID: 32217639 [TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats. Yoshiji H; Noguchi R; Kitade M; Kaji K; Ikenaka Y; Namisaki T; Yoshii J; Yanase K; Yamazaki M; Tsujimoto T; Akahane T; Kawaratani H; Uemura M; Fukui H J Gastroenterol; 2009; 44(5):483-91. PubMed ID: 19319465 [TBL] [Abstract][Full Text] [Related]